NASHVILLE, Tenn. / Oct 04, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 3Q Earnings Release Call | ||
When: | Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) | ||
How: | Live Audio over the Internet: | ||
CLICK HERE TO REGISTER | |||
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$387.98 |
| Daily Change: | -9.77 -2.46 |
| Daily Volume: | 1,802,296 |
| Market Cap: | US$100.130B |
July 23, 2024 April 26, 2024 April 03, 2024 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
